Hims and Hers Health (NYSE: HIMS - Get Free Report) and HeartSciences (NASDAQ: HSCS - Get Free Report) are both medical companies, but which is the superior business? We will compare the two companies
Hims & Hers Health expands into Canada via Livewell acquisition, targeting a large, underserved weight-loss market. Canadian entry leverages local leadership and expertise, aiming to replicate success
Hims & Hers launched in Canada after announcing the company completed its all-cash acquisition of Canadian digital health provider “Livewell”. The deal comes just one month before generic semaglut
Hims & Hers is set to acquire YourBio Health, adding bladeless microneedle tech to transform the blood collection experience.

Hims & Hers shares jump on expansion into Canada

12:17pm, Thursday, 04'th Dec 2025
US-based digital health company Hims & Hers Holdings Inc (NYSE:HIMS) is entering the Canadian market following its acquisition of Livewell, a Canadian telehealth platform focused on weight loss and ot
Hims and Hers (HIMS) is stepping into Canada with the kind of momentum that suggests its international chapter could be entering a new gear. After acquiring Livew
SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (NYSE: HIMS), the leading health and wellness platform in the United States, is now serving customers in Canada. This entry follows the recent

Hims & Hers Now Serving Customers in Canada

07:00am, Thursday, 04'th Dec 2025
MONTREAL--(BUSINESS WIRE)--Hims & Hers Health, Inc. (NYSE: HIMS), the leading health and wellness platform in the United States, is now serving customers in Canada. This entry follows the recent acqui
HIMS grows its telehealth-to-prescription model with new offerings in weight loss, hormone care and diagnostics.
SAN FRANCISCO & BOSTON--(BUSINESS WIRE)--Hims & Hers Health, Inc. (NYSE: HIMS), the leading health and wellness platform, today announced that it has entered into a definitive agreement to acquire You
New York, NY, Dec. 02, 2025 (GLOBE NEWSWIRE) -- GraniteShares, a one of the leading issuer of exchange-traded funds (ETFs), today announced the launch of two new additions to its growing YieldBOOST �
Zacks.com users have recently been watching Hims & Hers Health (HIMS) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Hims and Hers Health, Inc. (NYSE: HIMS - Get Free Report) has been assigned an average rating of "Reduce" from the fifteen brokerages that are presently covering the stock, Marketbeat reports. Three a
Hims & Hers and GoodRx are reshaping virtual care, but which one leads in platform strategy and patient engagement? Let's dive in.
The regulatory changes surrounding the weight loss treatment industry are having a large impact on Hims & Hers (HIMS 1.83%) stock.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE